Ost-müük Silk Road Medical, Inc - SILK CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | - | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.025457% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.003235% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Silk Road Medical Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Eelmine sulgemine* | N/A |
Avatud* | N/A |
Aastane muutus* | N/A |
Päeva ulatus* | N/A |
52 nädala ulatus | 28.98-58.04 |
Keskmine maht (10 päeva) | 587.20K |
Keskmine maht (3 kuud) | 12.75M |
Turukapitalisatsioon | 1.16B |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 38.73M |
Tulu | 150.75M |
EPS | -1.49 |
Dividendid (% kasumist) | N/A |
Beeta | 1.18 |
Järgmine tuluaruande kuupäev | Jul 24, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|
Silk Road Medical, Inc Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
Friday, June 9, 2023 | ||
Kellaaeg (UTC) (UTC) 21:30 | Riik US
| Sündmus Silk Road Medical Inc Annual Shareholders Meeting Silk Road Medical Inc Annual Shareholders MeetingForecast -Previous - |
Monday, July 24, 2023 | ||
Kellaaeg (UTC) (UTC) 10:59 | Riik US
| Sündmus Q2 2023 Silk Road Medical Inc Earnings Release Q2 2023 Silk Road Medical Inc Earnings ReleaseForecast -Previous - |
Monday, November 6, 2023 | ||
Kellaaeg (UTC) (UTC) 10:59 | Riik US
| Sündmus Q3 2023 Silk Road Medical Inc Earnings Release Q3 2023 Silk Road Medical Inc Earnings ReleaseForecast -Previous - |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 138.638 | 101.475 | 75.227 | 63.354 | 34.557 |
Tulu | 138.638 | 101.475 | 75.227 | 63.354 | 34.557 |
Kulud, Kokku | 37.876 | 25.446 | 21.291 | 15.927 | 10.874 |
Brutokasum | 100.762 | 76.029 | 53.936 | 47.427 | 23.683 |
Kogu tegevuskulu | 190.887 | 148.943 | 119.205 | 91.419 | 55.952 |
Müük/Üldine/admin kulud, kokku | 116.317 | 96.387 | 75.524 | 63.22 | 34.82 |
Uuringud ja arendus | 36.449 | 27.11 | 21.271 | 12.272 | 10.258 |
Tulud majandustegevusest | -52.249 | -47.468 | -43.978 | -28.065 | -21.395 |
Intressitulud (kulu), muud tulud, neto | -2.571 | -2.32 | -3.307 | -3.296 | -4.172 |
Muud, neto | -0.19 | -0.023 | -0.08 | -21.054 | -12.063 |
Netotulu enne makse | -55.01 | -49.811 | -47.365 | -52.415 | -37.63 |
Netotulu pärast makse | -55.01 | -49.811 | -47.365 | -52.415 | -37.63 |
Vähemuse intress | 0 | 0 | 0.001 | ||
Netotulu enne erikulusid | -55.01 | -49.811 | -47.365 | -52.415 | -37.629 |
Erakorralised kulud kokku | |||||
Netotulu | -55.01 | -49.811 | -47.365 | -52.415 | -37.629 |
Arvestatav tulu, v a erikulud | -55.01 | -49.811 | -47.365 | -52.415 | -37.629 |
Arvestatav tulu, koos erikuludega | -55.01 | -49.811 | -47.365 | -52.415 | -37.629 |
Jaotamisele kuuluv netotulu | -55.01 | -49.811 | -47.365 | -52.415 | -37.629 |
Keskmine jaotamisele kuuluv aktsia kohta | 35.7757 | 34.6354 | 32.9655 | 22.9567 | 30.229 |
Jaotatav EPS, v a erakorralised kulud | -1.53764 | -1.43815 | -1.4368 | -2.28321 | -1.2448 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
Jaotamisele kuuluv normaal-EPS | -1.53079 | -1.43815 | -1.40286 | -2.28321 | -1.2448 |
Ootamatud kulutused (tulu) | 0.245 | 0 | 1.119 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kogutulu | 40.131 | 40.071 | 37.374 | 33.173 | 28.021 |
Tulu | 40.131 | 40.071 | 37.374 | 33.173 | 28.021 |
Kulud, Kokku | 12.526 | 10.979 | 9.308 | 9.012 | 8.577 |
Brutokasum | 27.605 | 29.092 | 28.066 | 24.161 | 19.444 |
Kogu tegevuskulu | 57.041 | 52.701 | 46.6 | 47.612 | 43.975 |
Müük/Üldine/admin kulud, kokku | 34.082 | 32.522 | 28.821 | 27.7 | 27.275 |
Uuringud ja arendus | 10.433 | 9.2 | 8.471 | 10.655 | 8.123 |
Tulud majandustegevusest | -16.91 | -12.63 | -9.226 | -14.439 | -15.954 |
Intressitulud (kulu), muud tulud, neto | 0.594 | 0.044 | -1.097 | -0.909 | -0.609 |
Muud, neto | -0.144 | -0.028 | 0.004 | -0.05 | -0.116 |
Netotulu enne makse | -16.46 | -12.614 | -10.319 | -15.398 | -16.679 |
Netotulu pärast makse | -16.46 | -12.614 | -10.319 | -15.398 | -16.679 |
Netotulu enne erikulusid | -16.46 | -12.614 | -10.319 | -15.398 | -16.679 |
Netotulu | -16.46 | -12.614 | -10.319 | -15.398 | -16.679 |
Arvestatav tulu, v a erikulud | -16.46 | -12.614 | -10.319 | -15.398 | -16.679 |
Arvestatav tulu, koos erikuludega | -16.46 | -12.614 | -10.319 | -15.398 | -16.679 |
Jaotamisele kuuluv netotulu | -16.46 | -12.614 | -10.319 | -15.398 | -16.679 |
Keskmine jaotamisele kuuluv aktsia kohta | 38.5322 | 37.6292 | 35.304 | 35.1432 | 35.0233 |
Jaotatav EPS, v a erakorralised kulud | -0.42718 | -0.33522 | -0.29229 | -0.43815 | -0.47623 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Jaotamisele kuuluv normaal-EPS | -0.42718 | -0.33522 | -0.29229 | -0.43118 | -0.47623 |
Ootamatud kulutused (tulu) | 0 | 0 | 0.245 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Käibevarad kokku | 254.898 | 143.326 | 173.328 | 112.49 | 38.524 |
Raha ja lühiajalised investeeringud | 213.674 | 110.231 | 147.482 | 90.689 | 24.99 |
Raha ja ekvivalendid | 55.358 | 110.231 | 69.466 | 39.181 | 24.99 |
Laekumata arved, neto | 18.007 | 11.832 | 9.07 | 8.601 | 6.382 |
Accounts Receivable - Trade, Net | 18.007 | 11.832 | 9.07 | 8.601 | 6.382 |
Total Inventory | 19.293 | 17.851 | 9.989 | 10.322 | 5.744 |
Prepaid Expenses | 3.924 | 3.412 | 6.787 | 2.878 | 1.408 |
Total Assets | 269.685 | 156.625 | 179.314 | 137.402 | 42.743 |
Property/Plant/Equipment, Total - Net | 14.453 | 12.916 | 5.642 | 6.134 | 2.88 |
Property/Plant/Equipment, Total - Gross | 19.808 | 16.246 | 7.974 | 7.684 | 3.826 |
Accumulated Depreciation, Total | -5.355 | -3.33 | -2.332 | -1.55 | -0.946 |
Other Long Term Assets, Total | 0.334 | 0.383 | 0.344 | 0.554 | 1.339 |
Total Current Liabilities | 24.488 | 26.086 | 19.555 | 16.932 | 10.7 |
Accounts Payable | 2.523 | 2.379 | 2.598 | 1.898 | 1.252 |
Accrued Expenses | 21.712 | 19.645 | 16.751 | 15.034 | 9.448 |
Notes Payable/Short Term Debt | 0 | 3.905 | 0 | 0 | 0 |
Total Liabilities | 105.81 | 77.385 | 71.814 | 65.511 | 72.061 |
Total Long Term Debt | 74.596 | 44.786 | 48.533 | 44.879 | 44.201 |
Long Term Debt | 74.596 | 44.786 | 48.533 | 44.879 | 44.201 |
Other Liabilities, Total | 6.726 | 6.513 | 3.726 | 3.7 | 17.16 |
Total Equity | 163.875 | 79.24 | 107.5 | 71.891 | -29.318 |
Redeemable Preferred Stock | 0 | 0 | 0 | 121.144 | |
Preferred Stock - Non Redeemable, Net | -15.909 | ||||
Common Stock | 0.038 | 0.035 | 0.034 | 0.031 | 0.001 |
Additional Paid-In Capital | 507.715 | 367.907 | 346.318 | 263.384 | 4.557 |
Retained Earnings (Accumulated Deficit) | -343.712 | -288.702 | -238.891 | -191.526 | -139.111 |
Total Liabilities & Shareholders’ Equity | 269.685 | 156.625 | 179.314 | 137.402 | 42.743 |
Total Common Shares Outstanding | 38.356 | 34.9809 | 34.2496 | 31.2553 | 30.229 |
Lühiajalised investeeringud | 158.316 | 0 | 78.016 | 51.508 | 0 |
Long Term Investments | 0 | 18.224 | 0 | ||
Other Equity, Total | -0.166 | 0 | 0.039 | 0.002 | 0 |
Other Current Liabilities, Total | 0.253 | 0.157 | 0.206 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Käibevarad kokku | 230.254 | 254.898 | 146.987 | 146.919 | 127.768 |
Raha ja lühiajalised investeeringud | 189.067 | 213.674 | 105.132 | 108.871 | 93.602 |
Raha ja ekvivalendid | 50.427 | 55.358 | 51.306 | 87.637 | 93.602 |
Lühiajalised investeeringud | 138.64 | 158.316 | 53.826 | 21.234 | |
Laekumata arved, neto | 19.956 | 18.007 | 17.019 | 15.779 | 13.876 |
Accounts Receivable - Trade, Net | 19.956 | 18.007 | 17.019 | 15.779 | 13.876 |
Total Inventory | 17.182 | 19.293 | 20.293 | 17.616 | 17.726 |
Prepaid Expenses | 4.049 | 3.924 | 4.543 | 4.653 | 2.564 |
Total Assets | 259.587 | 269.685 | 162.544 | 162.721 | 143 |
Property/Plant/Equipment, Total - Net | 13.697 | 14.453 | 15.027 | 15.381 | 14.843 |
Other Long Term Assets, Total | 0.351 | 0.334 | 0.53 | 0.421 | 0.389 |
Total Current Liabilities | 20.87 | 24.488 | 23.933 | 21.241 | 29.499 |
Accounts Payable | 5.272 | 2.523 | 4.312 | 3.666 | 2.926 |
Accrued Expenses | 15.389 | 21.712 | 19.323 | 17.093 | 16.222 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 9.829 |
Other Current Liabilities, Total | 0.209 | 0.253 | 0.298 | 0.482 | 0.522 |
Total Liabilities | 101.974 | 105.81 | 105.346 | 102.692 | 75.293 |
Total Long Term Debt | 74.848 | 74.596 | 74.34 | 74.033 | 38.901 |
Long Term Debt | 74.848 | 74.596 | 74.34 | 74.033 | 38.901 |
Other Liabilities, Total | 6.256 | 6.726 | 7.073 | 7.418 | 6.893 |
Total Equity | 157.613 | 163.875 | 57.198 | 60.029 | 67.707 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
Common Stock | 0.039 | 0.038 | 0.035 | 0.035 | 0.035 |
Additional Paid-In Capital | 517.663 | 507.715 | 388.452 | 380.775 | 373.053 |
Retained Earnings (Accumulated Deficit) | -360.172 | -343.712 | -331.098 | -320.779 | -305.381 |
Other Equity, Total | 0.083 | -0.166 | -0.191 | -0.002 | |
Total Liabilities & Shareholders’ Equity | 259.587 | 269.685 | 162.544 | 162.721 | 143 |
Total Common Shares Outstanding | 38.7084 | 38.356 | 35.3811 | 35.1932 | 35.0736 |
Long Term Investments | 15.285 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Netotulu/algväärtus | -55.01 | -49.811 | -47.365 | -52.415 | -37.63 |
Raha majandustegevusest | -32.581 | -38.935 | -42.068 | -29.61 | -21.695 |
Raha majandustegevusest | 2.127 | 1.032 | 0.789 | 0.712 | 0.517 |
Mittelikviidsed varad | 26.328 | 16.326 | 9.695 | 25.139 | 16.457 |
Makstud intressid | 3.843 | 2.36 | 7.917 | 4.234 | 2.738 |
Muutused tööjõus | -6.026 | -6.482 | -5.187 | -3.046 | -1.039 |
Tulu investeeringutelt | -162.068 | 72.644 | -9.393 | -69.956 | -2.27 |
Kapitalikulutused | -5.005 | -4.758 | -0.842 | -0.535 | -2.276 |
Muud rahavood investeeringutelt, kokku | -157.063 | 77.402 | -8.551 | -69.421 | 0.006 |
Rahavood investeeringutelt | 139.699 | 6.978 | 81.746 | 113.757 | 15.424 |
Rahavoogudesse investeerimine | 0.032 | 0 | -0.232 | ||
Aktsiate emiteerimine (tagasiost), neto | 114.788 | 6.946 | 75.736 | 113.757 | 0.656 |
Laenu väljastamine (kustutamine), neto | 24.911 | 0 | 6.01 | 0 | 15 |
Rahaline kogumuutus | -54.95 | 40.687 | 30.285 | 14.191 | -8.541 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -16.46 | -55.01 | -42.396 | -32.077 | -16.679 |
Cash From Operating Activities | -12.147 | -32.581 | -29.857 | -25.131 | -14.725 |
Cash From Operating Activities | 0.699 | 2.127 | 1.465 | 0.922 | 0.42 |
Non-Cash Items | 7.805 | 26.328 | 19.311 | 12.55 | 5.365 |
Cash Interest Paid | 1.418 | 3.843 | 2.383 | 1.087 | 0.582 |
Changes in Working Capital | -4.191 | -6.026 | -8.237 | -6.526 | -3.831 |
Cash From Investing Activities | 6.106 | -162.068 | -57.117 | -24.222 | -2.072 |
Capital Expenditures | -0.287 | -5.005 | -3.438 | -3.049 | -2.072 |
Other Investing Cash Flow Items, Total | 6.393 | -157.063 | -53.679 | -21.173 | 0 |
Cash From Financing Activities | 1.11 | 139.699 | 27.972 | 26.759 | 0.168 |
Issuance (Retirement) of Stock, Net | 1.11 | 114.788 | 3.067 | 1.729 | 0.168 |
Net Change in Cash | -4.931 | -54.95 | -59.002 | -22.594 | -16.629 |
Financing Cash Flow Items | -1.095 | -0.97 | |||
Issuance (Retirement) of Debt, Net | 24.911 | 26 | 26 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
Wasatch Global Investors Inc | Investment Advisor/Hedge Fund | 10.5486 | 4085314 | 840776 | 2023-04-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.3833 | 3634041 | 77898 | 2023-03-31 | LOW |
Capital World Investors | Investment Advisor | 7.6603 | 2966730 | 0 | 2023-03-31 | LOW |
AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 6.3567 | 2461871 | -154924 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.7074 | 2210394 | 15827 | 2023-03-31 | LOW |
ClearBridge Investments, LLC | Investment Advisor/Hedge Fund | 4.4647 | 1729101 | 56517 | 2023-03-31 | LOW |
Deerfield Management Company, L.P. | Hedge Fund | 4.4557 | 1725640 | 329000 | 2023-03-31 | MED |
Kayne Anderson Rudnick Investment Management, LLC | Investment Advisor | 3.5417 | 1371666 | 21352 | 2023-03-31 | LOW |
American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 3.509 | 1359003 | 11514 | 2023-03-31 | LOW |
Bellevue Asset Management AG | Investment Advisor | 2.7621 | 1069739 | 57216 | 2023-03-31 | LOW |
Fred Alger Management, LLC | Investment Advisor/Hedge Fund | 2.6403 | 1022542 | 986309 | 2023-03-31 | MED |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.3829 | 922850 | 81604 | 2023-03-31 | LOW |
Jennison Associates LLC | Investment Advisor/Hedge Fund | 2.316 | 896956 | 220833 | 2023-03-31 | LOW |
Ensign Peak Advisors, Inc. | Foundation | 2.2931 | 888103 | 14158 | 2023-03-31 | LOW |
Millennium Management LLC | Hedge Fund | 2.2527 | 872457 | 312583 | 2023-03-31 | HIGH |
Lord, Abbett & Co. LLC | Investment Advisor | 2.0547 | 795766 | -130106 | 2023-03-31 | MED |
Baron Capital Management, Inc. | Investment Advisor/Hedge Fund | 2.0276 | 785281 | 0 | 2023-03-31 | LOW |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.9145 | 741464 | 424811 | 2023-03-31 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8729 | 725331 | 33968 | 2023-03-31 | LOW |
Next Century Growth Investors, LLC | Investment Advisor | 1.7024 | 659305 | -19661 | 2023-03-31 | MED |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group535K+
Kauplejad
87K+
Igakuiste aktiivsete klientide arv
$113M+
Igakuine investeerimise maht
$64M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Silk Road Medical, Inc Company profile
Ettevõttest Silk Road Medical, Inc
Silk Road Medical, Inc. on meditsiiniseadmete ettevõte. Ettevõte on välja töötanud lähenemise kaelaarterite haiguse raviks, mida nimetatakse transkarotiidse arteri revaskulariseerimiseks (TCAR). Ettevõtte TCAR tugineb kahele kontseptsioonile - minimaalselt invasiivne otsene juurdepääs kaelas asuvale kaelaarterile ja kiire verevoolu ümberpööramine protseduuri ajal, et kaitsta aju - ning ühendab endovaskulaarsete tehnikate eelised põhiliste kirurgiliste põhimõtetega. Ettevõtte ENROUTE Transcarotid Neuroprotection System (NPS) ja ENROUTE Transcarotid Stent System on tooted, mida kasutatakse TCARi puhul. ENROUTE transkarotiidistent on näidustatud kasutamiseks kõrge kirurgilise riskiga patsientidel ja on mõeldud kasutamiseks koos ENROUTE NPSiga TCAR-protseduuri ajal. ENROUTE Transcarotid NPS on seade, mida kasutatakse juurdepääsuks ühisele kaelaarterile ja ajutise verevoolu ümberpööramise algatamiseks, et kaitsta aju insuldi eest ENROUTE Transcarotid Stent'i paigaldamise ja implanteerimise ajal.
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
1213 Innsbruck Dr
94089-1317
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 535,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com